Walbert Timothy P's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Apr 1, 2022
- Accession no.
- 0001209191-22-021969
- Filed
- Apr 1, 2022
- Trade date
- Mar 30, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.26M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walbert Timothy PCIK 0001349376 | Director, Officer (Chairman, President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2022 | Ordinary Shares | SSaleDisposed | −14,520 | $104.61 | −$1,518,937.2 | 521,029 | Direct | |
| Mar 30, 2022 | Ordinary Shares | SSaleDisposed | −35,480 | $105.52 | −$3,743,849.6 | 485,549 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.